Find a doctor or nurse practitionerHow to find a family doctor, nurse practitioner or specialist and details about the Health Care
Learn MoreYour local hospitalHospitals often know which of their physicians are accepting new patients, and may be able to provide a few
Learn MoreFind driving directions, maps, live traffic updates and road conditions Find nearby businesses, restaurants and hotels
Learn More
How to find a family doctor, nurse practitioner or specialist and details about the Health Care Connect program.
If you’re on the Health Care Connect waitlist as of January 1, 2025, we will connect you to a family doctor or nurse practitioner by Spring 2026 as part of Ontario’s plan to connect every person in the province to primary care by 2029.
You may receive an official letter, email or text message from Health Care Connect asking you to confirm if you still need primary care, and if your information is up to date.
Heath Care Connect: Call 1 800 445 1822 press 5
You can start your search from:
Or you can can call Service Ontario:
1-888-218-9929
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between February 1 and 28, 2026. The next update is scheduled for May 2026.
Health Canada has published an updated Guidance on how to interpret significant change of a medical device. This update clarifies Health Canada’s current interpretation of what constitutes a significant change for Class III and Class IV medical devices.
Content Product Monograph update: Stivarga (regorafenib); Notice of authorization with conditions: Voxzogo (vosoritide for injection)
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to November 30, 2025. The next update of data is scheduled for early April, 2026.
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between January 1 and 31, 2026. The next update is scheduled for April 2026.
Announcement: Notice of intent to control zuranolone under the Controlled Drugs and Substances Act; Announcement: New clinical information resource on cannabis for medical purposes; PM update: Accutane, Epuris and Absorica LD (isotretinoin); Notice of authorization with conditions: Hyrnuo (sevabertinib): Notice of authorization with conditions: Ziihera (zanidatamab for injection); Medication Error Alert: Psyllium and the risk of choking
